- Tilray Brands’ premium cannabis brand Riff has launched its new Riff Boost beverage collection that features two new ready-to-drink THC and CBG-infused drinks
- Riff Boost is available in two new flavours, Tropical Burst and Vanilla Frost
- The drinks are are infused with a blend of nano-emulsified cannabinoids, ginseng extract and naturally occurring caffeine from guarana extract
- Tilray Brands, Inc. shares were down C$0.055, trading at C$3.02 as of 9:47 am ET.
Tilray Brands’ (TSX:TLRY; NDAQ:TLRY) premium cannabis brand Riff on Thursday launched its new Riff Boost beverage collection that features two new ready-to-drink THC- and CBG-infused drinks.
Available in two flavours, Tropical Burst and Vanilla Frost, each of the Riff Boost drinks are infused with a blend of nano-emulsified cannabinoids containing 10mg THC and 10mg CBG, ginseng extract, and 30mg of naturally occurring caffeine from guarana extract, according to Tilray’s news release.
RIFF’s cannabis infused beverages are available in 355 mL cans in Canada at select regions and retailers, including Alberta, Manitoba and Ontario. Riff products are produced on behalf of its licensed producer, Aphria Inc.
Tilray Brands, Inc. is a leading global cannabis-lifestyle and consumer packaged goods company with operations in Canada, the United States, Europe, Australia and Latin America.
Tilray’s mission is to be the trusted partner for its patients and consumers by providing them with a cultivated experience and health and well-being through high-quality, differentiated brands and innovative products. Tilray’s production platform supports more than 20 brands in more than 20 countries, including comprehensive cannabis offerings, hemp-based foods, and alcoholic beverages.
Tilray Brands, Inc. shares were down 1.79 per cent (C$0.055), trading at C$3.02 as of 9:47 am ET.
Join the discussion: Find out what everybody’s saying about this stock on the Tilray Brands, Inc. Bullboard, and check out the rest of Stockhouse’s stock forums and message boards.
The material provided in this article is for information only and should not be treated as investment advice. For full disclaimer information, please click here.